# Guaifenesin

NDC: 76162-031
Generic name: Guaifenesin
Labeler / Manufacturer: TOPCO ASSOCIATES LLC
Product type: HUMAN OTC DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20260422

FDA application: ANDA210453

## Active ingredients

- GUAIFENESIN: 1200 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"76162-031"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=76162-031
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3a6e96d3-ac86-f388-e063-6394a90ade2d
